Interaction Effects of Temperature and Ozone
TROPICOZ
1 other identifier
interventional
16
1 country
1
Brief Summary
Purpose: The purpose of this protocol is to understand how individuals respond to the air pollutant ozone at elevated temperatures. Ultimately, this will help us understand what the risks from poor air quality are during a heat wave. Participants: We will recruit up to 30 healthy adults, 18-55 years old, to participate in this study. Procedures (methods): Subjects will be exposed to clean air and to 0.3 ppm of ozone for 2 hours with intermittent exercise in a controlled environment chamber. For each exposure the temperature in the chamber will be between 31-34oC (88-93 oF). Because the aim of the study is to mimic high exposure during a heat wave, we will perform exposures only on days when mean ambient temperatures was less than 24 oC in Chapel Hill on the previous day. Primary endpoints will include spirometry and Heart Rate Variability monitoring. Secondary endpoints will include analysis of blood clotting/coagulation factors, and analysis of soluble factors present in plasma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 22, 2013
CompletedFirst Posted
Study publicly available on registry
November 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedFebruary 10, 2015
February 1, 2015
2.5 years
October 22, 2013
February 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Forced expired volume in the first second (FEV1)
Forced expired volume in the first second (FEV1) is determined by spirometry performed on a dry seal spirometer interfaced to a computer.
Pre exposure to 24hours post exposure
Secondary Outcomes (4)
Index of clotting/coagulation factor
Pre exposure to 24hours post exposure
Index of inflammatory markers
Pre exposure to 24hours post exposure
Forced Vital Capacity
Pre exposure to 24hours post exposure
Changes in heart rate variability
Pre exposure to 24hours post exposure
Study Arms (2)
Clean Air
SHAM COMPARATORExposure to clean air will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus.
Ozone
EXPERIMENTALExposure to ozone will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus.
Interventions
Each subject will be exposed to clean air for 2 hours. The exposure atmosphere will be at a temperature between 31-34oC (88-93 oF) and approximately 40 + 10% RH. Subjects will exercise on a bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.
Each subject will be exposed up to 0.3ppm ozone for 2 hours. The exposure atmosphere will be at a temperature between 31-34oC (88-93 oF) and approximately 40 + 10% RH. Subjects will exercise on a bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.
Eligibility Criteria
You may qualify if:
- \. Pass a physical exam performed by study physicians during the screening visit under a separate protocol.
- \. Normal lung function:
- FVC \> 75 % of that predicted for gender, ethnicity, age and height.
- FEV1 \> 75 % of that predicted for gender, ethnicity, age and height.
- FEV1/FVC ratio \> 75 % of predicted values. 3. Oxygen saturation of \> 96 %. 4. Ability to tolerate intervals of moderate exercise.
You may not qualify if:
- \. A history of chronic illnesses such as diabetes, rheumatological diseases, immunodeficiency state, known clinically significant cardiac disease (including myocardial infarction, congestive heart failure and angina), chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma and lung cancer.
- \. Smoking history within 2 years of the study. 5. Untreated hypertension (≥ 150 systolic, ≥ 90 diastolic). 6. Skin diseases or sensitivity precluding the use of ECG electrodes. 7. Symptom score greater than 21 (out of a possible 40-see accompanying score sheet) for total symptom score. Only one score may be equal to 3.
- \. Dementia. 9. Unspecified illness or condition which in the judgment of the investigator might increase the risk associated with inhalation challenge or exercise.
- \. Subjects who do not understand or speak English. 11. Subjects who are unable to perform moderate exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.S. EPA Human Studies Facility
Chapel Hill, North Carolina, 27514, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Diaz-Sanchez, PhD
U.S. Environmental Protection Agency
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Clinical Research Branch
Study Record Dates
First Submitted
October 22, 2013
First Posted
November 11, 2013
Study Start
September 1, 2011
Primary Completion
March 1, 2014
Study Completion
January 1, 2015
Last Updated
February 10, 2015
Record last verified: 2015-02